Biography
Dr. Lin Cheng is a distinguished Chief Oncologist at Shanghai East Hospital, Tongji University with 20 years of dedicated clinical practice. Over the course of an extensive career, Lin Cheng has treated thousands of international and domestic patients, establishing a reputation for clinical excellence, evidence-based decision-making, and compassionate, family-centered care.
Clinical Focus & Expertise
Dr. Lin Cheng specializes in the diagnosis and management of complex medical conditions, with particular expertise in CAR-T cell therapy, Lymphoma, Hepatocellular carcinoma, Tumor genomic profiling, Targeted therapy. The clinical practice combines current best-evidence medicine with personalized treatment planning — recognizing that every patient brings a unique medical history, lifestyle, and set of life priorities to the consultation room.
Conditions Treated
Patients consult Dr. Lin Cheng for the following conditions and procedures:
- CAR-T cell therapy
- Lymphoma
- Hepatocellular carcinoma
- Tumor genomic profiling
- Targeted therapy
Education & Training
- MD Zhejiang University · Fellowship Princess Margaret Cancer Centre Toronto
Professional Credentials & Memberships
- American Society of Clinical Oncology (ASCO) Affiliate
- European Society for Medical Oncology (ESMO)
- International Association for the Study of Lung Cancer
International Patient Care
Dr. Lin Cheng communicates with patients in English, Chinese, German, providing direct rapport without the need for translation in those languages. The hospital's international department coordinates dedicated case managers, multilingual interpreters for additional languages, simplified visa documentation, and personalized treatment itineraries for travelers from over 60 countries.
“Every patient deserves more than a diagnosis — they deserve a treatment plan that respects who they are, where they come from, and what matters most to them.”
Education
MD Zhejiang University · Fellowship Princess Margaret Cancer Centre Toronto
Certifications
- American Society of Clinical Oncology (ASCO) Affiliate
- European Society for Medical Oncology (ESMO)
- International Association for the Study of Lung Cancer